Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Thrombosis 2Venous Thromboembolism 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Myeloproliferative Disorders 1Multiple Myeloma 1Lymphoma, Follicular 1Ischemic Stroke 1Hypertension, Portal 1Endometrial Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Cancer-associated Thrombosis 1Adenocarcinoma 1

Interventions

Cyclophosphamide 87fludarabine phosphate 86Peripheral Blood Stem Cell Transplantation 71Mycophenolic Acid 58Tacrolimus 57Busulfan 57Whole-Body Irradiation 55Antilymphocyte Serum 47Cyclosporine 46fludarabine 39Methotrexate 38Filgrastim 38Melphalan 32ruxolitinib 30Cytarabine 30Radiotherapy 27Azacitidine 23Etoposide 21Methylprednisolone 20Cord Blood Stem Cell Transplantation 18Specimen Handling 15Sirolimus 15Granulocyte Colony-Stimulating Factor 15Decitabine 15Biopsy 15Flow Cytometry 14Cyclosporins 14Alemtuzumab 14thymoglobulin 13venetoclax 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Myeloproliferative Disorders × Anticoagulants × Clear all
NCT04527666 2020-08-27

Anticoagulation in Gastroesophageal Varices and JAK2 Mutation

Shanghai Zhongshan Hospital

Unknown
40 enrolled
Myeloid

Hypertension, Portal, Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡